Actively Recruiting

Phase Not Applicable
Age: 30Years +
All Genders
Healthy Volunteers
NCT04250493

Insulin Resistance in Multiple System Atrophy

Led by University Hospital, Bordeaux · Updated on 2025-07-20

124

Participants Needed

1

Research Sites

365 weeks

Total Duration

On this page

Sponsors

U

University Hospital, Bordeaux

Lead Sponsor

U

University of Bordeaux

Collaborating Sponsor

AI-Summary

What this Trial Is About

Multiple system atrophy (MSA) is a rare and fatal neurodegenerative disorder. The pathologic hallmark is the accumulation of aggregated alpha-synuclein in oligodendrocytes forming glial cytoplasmic inclusions. Some symptomatic treatments are available while disease-modification remains an unmet treatment need. Post-mortem findings suggest insulin resistance, i.e. reduced insulin signaling, in the brains of MSA patients. The aim of this study is to complete the target validation of insulin resistance for future treatment trials.

CONDITIONS

Official Title

Insulin Resistance in Multiple System Atrophy

Who Can Participate

Age: 30Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with possible or probable multiple system atrophy (MSA) based on clinical criteria
  • Age over 30 years
  • Ability to provide written informed consent
  • Coverage by the national health system
  • Control participants without neurological disorders
  • Controls aged over 30 years
  • Controls able to provide written informed consent
  • Controls covered by the national health system
Not Eligible

You will not qualify if you...

  • Diagnosis of diabetes
  • Treatment with corticosteroids, estrogen, atypical antipsychotics, or anti-retroviral drugs
  • Patient under legal guardianship
  • Inability to give consent
  • Presence of any other neurological disorder
  • Pregnancy or breastfeeding
  • Montreal Cognitive Assessment (MOCA) score less than or equal to 21
  • Contraindications to undergoing MRI scans

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

CHU de Bordeaux

Bordeaux, France, 33 076

Actively Recruiting

Loading map...

Research Team

W

Wassilios MEISSNER

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

HEALTH_SERVICES_RESEARCH

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here